UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Tracking error happens when a fund deviates from its index due to replication method, fees, or liquidity. Grasp the causes to improve tracking.
22,885 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A Senate staff brief on the ROAD to Housing Act flags design flaws and local zoning reliance, signaling lenders and b...
PennyMac’s Third-Party Origination unit rolls out a seven-program non-QM suite to broaden options for borrowers with ...
Cruise stocks are among the S&P 500’s biggest decliners as Middle East tensions and higher fuel costs bite into deman...
Oil futures rose midweek as markets priced in a possible emergency release from the U.S. Strategic Petroleum Reserve ...
RZC Investments, the Walton family–funded private equity arm, has paused new investments while it reevaluates its fun...
Retirement savings aren’t built in a single year—they grow through key age milestones. This guide shows what to aim f...
Walmart beat Q4 estimates on earnings and revenue but guided FY27 growth below consensus, sparking bearish chatter fr...
Navigator (NVGS) 2025 earnings paint a picture of a niche LNG carrier operator balancing utilization, rates and lever...
As allogene (allo) 2025 earnings loom, investors weigh pipeline progress, collaboration milestones, and cash runway. ...
A new Colorado bill could tax income that doesn't really exist by altering how the AMT and net operating losses are t...
U.S. equities climbed on Friday as top performing stocks led a broad rally, with technology and energy names pushing ...